COLE PIZZINGRILLI: Open Payments
NPI 1619210457 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,845 in 150 payments from 34 companies in 2025. Trend: 2023 $2,647 · 2024 $2,325 · 2025 $2,845
Food & beverage: $2,845
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $476 |
| Novo Nordisk Inc | 13 | $269 |
| ABBVIE INC. | 12 | $228 |
| PFIZER INC. | 14 | $202 |
| Lilly USA, LLC | 9 | $179 |
| Verona Pharma, Inc. | 14 | $171 |
| Teva Pharmaceuticals USA, Inc. | 6 | $134 |
| Neurocrine BioSciences, Inc. | 6 | $121 |
| Axsome Therapeutics, Inc. | 4 | $112 |
| Lundbeck LLC | 5 | $99 |
Products named: AIRSUPRA, FARXIGA, Wegovy, Ohtuvayre, ELIQUIS, REXULTI, INGREZZA, QULIPTA.
Industry payments across PA — which companies pay providers there.
